Clyde W. Yancy, MD, MSc, discusses the increased risk faced by patients with COVID-19 and cardiovascular disease, COVID-19 as it relates to ACE inhibitors and ARBs, racial disparity in COVID-19 cases, and other topics related to treating cardiovascular patients during the COVID-19 pandemic.